The isolation of recombinants between related orbiviruses.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 722283)

Published in J Gen Virol on November 01, 1978

Authors

B M Gorman, J Taylor, P J Walker, P R Young

Articles by these authors

(truncated to the top 100)

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging (1999) 13.26

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89

SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett (1995) 9.62

Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study. Dev Psychopathol (1999) 5.90

Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol (1989) 5.48

Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39

Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23

An investigation of traveller's diarrhoea. Lancet (1970) 4.99

Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 4.96

Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol (1988) 4.59

Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med (1994) 4.20

A specific base transition occurs on replicating hepatitis delta virus RNA. J Virol (1990) 4.05

Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol (1988) 4.05

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem (1998) 3.88

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med (1994) 3.72

Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology (1996) 3.60

Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol (1990) 3.57

Inhibition of interferon action by actinomycin. Biochem Biophys Res Commun (1964) 3.55

NYVAC: a highly attenuated strain of vaccinia virus. Virology (1992) 3.38

A study of Escherichia coli isolated from chronic urinary infection. J Med Microbiol (1969) 3.32

Template switching by reverse transcriptase during DNA synthesis. J Virol (1990) 2.98

Using nurses for preventive activities with computer assisted follow up: a randomised controlled trial. BMJ (1989) 2.95

Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study. Lancet (1977) 2.90

Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res (2001) 2.90

Malpractice claims against family physicians are the best doctors sued more? J Fam Pract (1999) 2.87

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85

Immunization against Diphtheria with Alum-precipitated Toxoid-II. Br Med J (1942) 2.77

Psychotic illness following 'mabi bark tea' consumption. Br J Psychiatry (1992) 2.72

The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63

A new nomenclature for IL-1-family genes. Trends Immunol (2001) 2.57

Comparison of influenza serological techniques by international collaborative study. Vaccine (1994) 2.55

Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem (1996) 2.55

Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A (1997) 2.54

MutS mediates heteroduplex loop formation by a translocation mechanism. EMBO J (1997) 2.52

A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol (1994) 2.42

Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol (1993) 2.40

Tumor necrosis factor-alpha expression in ischemic neurons. Stroke (1994) 2.37

Transient Induction of Phenylalanine Ammonia-Lyase and 4-Coumarate: CoA Ligase mRNAs in Potato Leaves Infected with Virulent or Avirulent Races of Phytophthora infestans. Plant Physiol (1987) 2.36

Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol (1987) 2.36

Assembly of hepatitis delta virus particles. J Virol (1992) 2.36

Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem (1998) 2.32

Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans. Cereb Cortex (2001) 2.32

Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem (2000) 2.24

A statement on the generalist physician from the American Boards of Family Practice and Internal Medicine. JAMA (1994) 2.16

Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci U S A (2000) 2.16

5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther (1991) 2.14

Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem (1998) 2.12

Immunisation with canarypox virus expressing rabies glycoprotein. Lancet (1992) 2.09

Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol (1996) 2.09

Rapid immune response to influenza vaccination. Lancet (1993) 2.09

Diagnosis and initial management of blunt pancreatic trauma: guidelines from a multiinstitutional review. Ann Surg (1998) 2.07

Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology (1998) 2.05

Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci (1982) 2.03

Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen. J Virol (1990) 2.03

A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem (1997) 2.00

Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun (1997) 1.99

Hereditary haemorrhagic telangiectasia, an Australian cohort: clinical and investigative features. Intern Med J (2014) 1.98

The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem (1988) 1.95

Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem (1990) 1.94

Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis. J Virol (1992) 1.94

Activation of the p38 mitogen-activated protein kinase by type I interferons. J Biol Chem (1999) 1.94

Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans R Soc Trop Med Hyg (1998) 1.91

Structural basis of inhibitor selectivity in MAP kinases. Structure (1998) 1.89

Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther (1992) 1.88

The stability and properties of bimolecular lipid leaflets in aqueous solutions. J Theor Biol (1963) 1.80

Self-ligating RNA sequences on the antigenome of human hepatitis delta virus. J Virol (1989) 1.78

Ketamine sedation for children in the emergency department. Emerg Med (Fremantle) (2001) 1.78

Performances of family practice diplomates on successive mandatory recertification examinations. Acad Med (1993) 1.75

Cloned hepatitis delta virus cDNA is infectious in the chimpanzee. J Virol (1989) 1.75

Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail (1999) 1.75

A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol (2001) 1.73

Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem (2001) 1.72

Outbreak of infantile gastro-enteritis caused by Escherichia coli O114. Arch Dis Child (1970) 1.71

The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity. J Virol (1991) 1.70

Intragenic amplification and divergence in the mouse alpha-fetoprotein gene. Nature (1981) 1.69

A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett (1996) 1.68

Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology (1982) 1.67

Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine (1991) 1.66

Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study. Neurology (2010) 1.66

Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med (1999) 1.65

Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg (1996) 1.65

Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol (2001) 1.64

Controlling deaths from volatile substance abuse in under 18s: the effects of legislation. BMJ (1992) 1.63

The variation of capacitance and conductance of bimolecular lipid membranes with area. J Theor Biol (1965) 1.62

The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J Virol (1993) 1.62

Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem (1998) 1.60

Acute lobar atelectasis. A comparison of two chest physiotherapy regimens. Chest (1990) 1.59

Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol (1999) 1.59

Avoided and avoidable risks of cancer. Carcinogenesis (1997) 1.58

Long-term outcome of episodes of major depression. Clinical and public health significance. JAMA (1984) 1.58

Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem (2000) 1.58

Modifications of testosterone-dependent behaviors by estrogen receptor-alpha gene disruption in male mice. Endocrinology (1998) 1.57

Polar group orientation and the electrical properties of lecithin bimolecular leaflets. J Theor Biol (1965) 1.57

T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood (1998) 1.57

Combined Active and Passive Immunization against Diphtheria: II. Control of Epidemics in the Field. Br Med J (1941) 1.57

Ribonucleoprotein complexes of hepatitis delta virus. J Virol (1993) 1.56

Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J Gen Virol (2005) 1.55

Specificities involved in the initiation of retroviral plus-strand DNA. J Virol (1990) 1.55

Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group. Epilepsia (1996) 1.54